IGC Pharma, Inc.IGCNYSE
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+193.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+193.8%/yr
vs -41.3%/yr prior
Acceleration
+235.1pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
25.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.65M+407.1%
2025$325000.00+110.1%
2024$-3.20M-5026.2%
2023$65000.00-84.2%
2022$412000.00+573.6%
2021$-87000.00+80.7%
2020$-451000.00-182.3%
2019$548000.00+18457.4%
2018$2953.00-98.6%
2017$215955.00-